The latest news & stories from the Providence Research Network
-
Read ArticleProstate cancer study includes a tumor test to personalize treatment
A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.
-
Read ArticleThe connection between dysautonomia and long COVID
Learn about dysautonomia, its symptoms, and how it's connected to long COVID. Discover treatment options and expert insights at Providence.
-
Read ArticleCan a community & health system partnership improve Black birth outcomes?
A research collaboration between CORE, PSU researcher Dr. Roberta Hunte and the Healthy Birth Initiative (HBI), is studying the impact of a cross-sector partnership on Black maternal health outcomes.
-
Read ArticlePersonalized cancer peptide vaccine shows remarkable promise against glioblastoma
A novel peptide vaccine against glioblastoma, a deadly brain tumor, is offering hope to some patients thanks to the work of an international effort including Providence's Santosh Kesari, MD, PhD.
-
Read ArticleDr. Walter Urba announces retirement from Providence
Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.
-
Read ArticleProvidence Swedish team successfully implants first-of-its-kind device for heart valve repair
The procedure using the new TriClip to repair a leaky tricuspid valve was also a first in the Pacific Northwest.
-
Read ArticleDr. Bernard Fox honored for his lifetime contributions to cancer research
Prominent cancer scientist Dr. Bernard Fox recognized for his work to advance the field of cancer immunotherapy through increasing public understanding, awareness and research efforts.
-
Read ArticleExamining the efficacy and safety of weight loss medications in the real world
A first-of-its-kind study on the efficacy and safety of weight loss medications in the real world is helping to provide clinicians with new is helping to provide clinicians with valuable new evidence.
-
Read ArticleSt. Pat's only one of five global sites for groundbreaking APOLLO research trial
-
Read ArticlePromising advances in treating TNBC: Two studies offer hope
Although chemotherapy is the cornerstone treatment for triple negative breast cancer, survival outcomes remain disappointing. Two studies could help improve treatment options.
-
Read ArticleThe evolution of cancer immunotherapy: Dr. Urba shares his insights
Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.
-
Read ArticleProvidence launches groundbreaking study to elevate real-world use of multi-cancer early detection
Over the next three years, this study seeks to identify the patterns of access and use of cancer services among high-risk patients to understand how to guide them toward quality care.
-
Read Article2023 research report highlights breadth and impact of research at Providence
Providence researchers conducted over 2400 studies in 2023, according to the 2023 Providence Research Network Annual Report
-
Read ArticlePioneering research to create better solutions for prostate cancer
Learn more about a clinical trial for men with metastatic prostate cancer.
-
Read ArticleProvidence Swedish helps tackle Snohomish County overdose crisis from emergency departments
In North Puget Sound, Providence Swedish has implemented solutions to address opioid overdoes, including participating in grant programs and research to discover addiction treatments that work.
-
Read ArticleWith the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model
A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.
-
Read ArticleCancer studies seek to harness the power of the immune system
Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.
-
Read ArticleProvidence researchers contribute study findings at ASCO 2024 meeting, May 31- June 3
The annual meeting of cancer experts is a platform to collaborate and accelerate cancer research findings into clinical applications.
-
Read ArticleAngiosarcoma on the rise: new study reveals implications for cancer care and research
The largest study of angiosarcoma published to date, co-authored at Providence, describes the incidence and presentation patterns of angiosarcoma, a rare but potentially deadly cancer.
-
Read ArticleProvidence researchers conducted over 2400 studies in 2023, according to new report
The 2023 Providence Research Network annual report, released on Clinical Trials Day 2024, highlights the breadth and impact of research at Providence.
-
Loading More...
